News & Events

Andover, Mass. – After more than 15 years of building a reputation of supplying high-quality raw materials in the life science industry, OYC Americas announced today that it has partnered with two reputable makers of health supplements to expand its … Continue reading →

OYC Americas is pleased to offer our Recombinant Enzymes for Clinical Chemistry. Please download our latest list of Recombinant Enzymes for Clinical Chemistry.

ANDOVER, MA. July 24, 2009. OYC Americas exhibited at the 2009 AACC Clinical Lab Expo held at McCormick Place Convention Center, Chicago, IL (July 21 to 23). OYC Americas launched its new brand image and marketing campaign to the clinical … Continue reading →

OYC Americas is pleased to announce that it will be exhibiting during the AACC Clinical Lab Expo 2009 which is being held at McCormick Place Convention Center, Chicago, IL from July 21-23, 2009. OYC Americas’ booth number is 3671. Meeting … Continue reading →

OYC Americas, Inc. is pleased to announce the launch of recombinant human soluble RANKL (sRANKL) to support osteoporosis and bone metabolism research initiatives. Receptor activator of NF-kB ligand (RANKL), also designated TRANCE, OPGL and ODF, is a member of the … Continue reading →

Andover, MA. OYC International officially launched its new corporate name and brand image, OYC Americas. This important change is a reflection of our new role and responsibility for the OYC group to expand business and market share in North and … Continue reading →